Ticker Details
Citius Pharmaceuticals, Inc. Citius Pharmaceuticals Inc is a specialty pharmaceutical company engaged in development and commercialization of therapeutic products for markets using patented or proprietary formulations and modified drug delivery technology.
IPO Date:	June 9, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$16.48M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.08 | 5.21%
Avg Daily Range (30 D):	$0.04 | 6.97%
Avg Daily Range (90 D):	$0.04 | 5.67%

Institutional Daily Volume
Avg Daily Volume:	1.6M
Avg Daily Volume (30 D):	.66M
Avg Daily Volume (90 D):	.63M

Trade Size
Avg Trade Size (Sh.):	417
Avg Trade Size (Sh.) (30 D):	358
Avg Trade Size (Sh.) (90 D):	376

Institutional Trades
Total Institutional Trades:	45
Avg Institutional Trade:	$2.78M
Avg Institutional Trade (30 D):	$6.8M
Avg Institutional Trade (90 D):	$6.8M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$6.35M
Avg Closing Trade (30 D):	$6.8M
Avg Closing Trade (90 D):	$6.8M
Avg Closing Volume:	149.91K

News

Feb 13, 2026 @ 1:00 PM Citius Pharmaceuticals, Inc. Announces First Repor... Source: Prnewswire

Feb 13, 2026 @ 1:00 PM Citius Oncology, Inc. Announces First Reported Rev... Source: Prnewswire

Dec 24, 2025 @ 2:04 PM Stock Market Today: Dow Jones, Nasdaq Futures Slip... Source: Rishabh Mishra

Dec 10, 2025 @ 9:30 PM Citius Oncology Announces Closing of $18 Million C... Source: Prnewswire

Dec 9, 2025 @ 1:30 PM Citius Oncology Announces $18 Million Concurrent R... Source: Prnewswire

Financials
	TTM	Q3 2026	Q2 2026
Basic EPS	$-1.78	$-.34	$-.95
Diluted EPS	$-1.78	$-.34	$-.95
Revenue	$7.11M	$1.49M	$1.67M
Gross Profit		$1M	$1.34M
Net Income / Loss	$-58.17M	$-11.92M	$-28.11M
Operating Income / Loss	$-61.38M	$-11.73M	$-32.19M
Cost of Revenue		$.49M	$.33M
Net Cash Flow	$13.76M	$12.42M	$-3.13M
PE Ratio

Splits
Nov 26, 2024	1:25
Jun 09, 2017	1:15
Sep 12, 2014	5:8